OneSight Research Foundation Awards $145,000 in Grants


The OneSight Research Foundation recently awarded $145,000 to four organizations that support diabetic retinopathy research:

  • Cedars-Sinai Medical Center, Los Angeles, CA receives $35,000 to support research toward a target therapy in the growth of leaky abnormal retinal vessels due to proliferative diabetic retinopathy, the most common blinding disease in working age adults worldwide.
  • Juvenile Diabetes Research Foundation, Dallas, TX is supported with a $50,000 grant to research vascular endothelial growth factor (VEGF) proteins in tissues linked to the development of diabetic complications. The purpose of this project is to clarify the inter-connection pathways of VEGF signaling in the diabetic eye and kidney.
  • New England College of Optometry in Boston is granted $20,000 to continue a study to determine whether the application of insulin eye drops can prevent or even reverse diabetic retinopathy (DR).
  • Western University of Health Sciences in Pomano, CA – receives $40,000 to understand the pathophysiology of DR. The results may allow a selection of targets for developing newer therapeutic agents and to validate therapies currently under development.

The Foundation Board meets twice a year to award researchers who submit projects that show promise for new treatments or a cure for diabetic retinopathy, the number one cause of blindness in working-age adults. This vision-threatening disease leaves 24,000 people blind annually.

Upcoming Events

  1. June 11, 2012

    Par for Sight

    Mason, Ohio

    OneSight’s annual golf outing brings hundreds of vendors from across the country to golf at Cincinnati’s premier courses.
    Read More »